In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 62348-13-4, name is Isoxazole-5-carbonyl chloride, introducing its new discovery. Product Details of 62348-13-4
A process for preparing N-(substituted)-C- (substituted methyl)-oxazolidinones, C-(substituted methyl)-oxazolidinones, and N-(substituted)-C- (substituted ethyl)-oxazolidinones, preferably chiral, from optically active C-(protected oxymethyl) oxazolidinones is described. The process can be used to produce combinatorial libraries of the above substituted oxazolidinones in a two or three step reaction comprising a plurality of reagents differing in numbers of carbons or particular substituted oxazolidinones. A number of substituted oxazolidinones produced using the above process have been discovered to have antimicrobial activity.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 62348-13-4, and how the biochemistry of the body works.Product Details of 62348-13-4
Reference：
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem